About Daicel Pharma Services
Daicel Pharma Services is a company based in Hyderabad (India) founded in 2019 by Ch Lakshmi Narayana. It operates as a B2B. The company has 368 employees. Daicel Pharma Services offers products and services including Analytical Testing Services, Peptide Bioassays, and Extractable and Leachable Studies. Daicel Pharma Services operates in a competitive market with competitors including AlphaLab Health, cGMP Validation, Sublime Stericeuticals, Rubizon and Wickham Laboratories, among others.
- Headquarter Hyderabad, India
- Employees 368
- Founders Ch Lakshmi Narayana
- SectorsHealthcareConsumer
- Email••••••••
- Website daicelpharmaservices.com
- Social LinkedIn YouTube
- Legal Name Daicel Chiral Technologies (India) Private Limited.
- Date of Incorporation 02 Apr, 2008
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹162 Cr
FY 2025 · +30% YoY
- Net Profit₹6.82 Cr
FY 2025 · 4% margin
- EBITDA₹27.02 Cr
FY 2025 · 17% margin
- Employee Count368
Associated legal entities of Daicel Pharma Services
Daicel Pharma Services operates through Daicel Chiral Technologies (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daicel Chiral Technologies (India) Private Limited CIN U24100TG2008PTC058509 | Active | 02 Apr 2008 | Hyderabad, Telangana | ₹162 Cr | 368 | 5 | View details |
Products & Services of Daicel Pharma Services
Daicel Pharma Services offers a comprehensive portfolio of products and services, including Analytical Testing Services, Peptide Bioassays, and Extractable and Leachable Studies.
Offers testing for drug development and safety analysis
Conducts safety studies for pharmaceutical peptides
Analyzes materials for potential contaminants in drugs
Apps and channels of Daicel Pharma Services
its YouTube channel Daicel Chiral Technologies (India) Pvt Ltd has 42 subscribers.
Board of directors of Daicel Chiral Technologies (India) Private Limited (Daicel Pharma Services)
Daicel Chiral Technologies (India) Private Limited is the primary company behind Daicel Pharma Services. The board of Daicel Chiral Technologies (India) Private Limited currently have 5 directors; the longest-serving is Lakshmi Narayana Chennuru, appointed in 2012. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lakshmi Narayana Chennuru DIN 05314602 | Managing Director | 27 Jun 2012 | 14 yrs 3 mo | Daicel Chiral Technologies (India) Private Limited |
| Tatsushi Murakami DIN 07562247 | Director | 20 Jul 2016 | 10 yrs 2 mo | Daicel Chiral Technologies (India) Private Limited |
| Seiji Sakano DIN 09637449 | Director | 15 Jun 2022 | 4 yrs 3 mo | Daicel Chiral Technologies (India) Private Limited |
| Kenichiro Miyazawa DIN 11096790 | Director | 13 May 2025 | 1 yr 4 mo | Daicel Chiral Technologies (India) Private Limited |
| Hideaki Yamamoto DIN 11097554 | Director | 13 May 2025 | 1 yr 4 mo | Daicel Chiral Technologies (India) Private Limited |
People of Daicel Pharma Services
1 people are tracked at Daicel Pharma Services (1 in leadership); the tracked headcount is 368.
| Name | Role | Group |
|---|---|---|
Ch Lakshmi Narayana | Founder, MD | Leadership |
Complete people profiles for Daicel Pharma Services
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Daicel Pharma Services
Figures of Daicel Chiral Technologies (India) Private Limited, the primary company behind Daicel Pharma Services, for FY 2025. Revenue was ₹162 Cr (+30% year on year). Net profit was ₹6.82 Cr (4% margin). EBITDA was ₹27.02 Cr (17% margin). Revenue has grown at a compounded annual rate of +10% over three years and +21% over five years.
- ₹162 CrRevenue · FY 2025 · +30% YoY
- ₹6.82 CrNet profit · 4% margin
- ₹27.02 CrEBITDA · 17% margin
- ₹0.44 CrPaid-up capital
- 368Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daicel Chiral Technologies (India) Private Limited are on its company page.
Detailed financial statements for Daicel Pharma Services
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Daicel Pharma Services
Daicel Pharma Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AlphaLab Health, cGMP Validation, Sublime Stericeuticals, Rubizon and Wickham Laboratories, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alphalabhealth.org | 2021 | Pittsburgh, United States | – | – | Market research for pharmaceuticals is provided by AlphaLab Health. | |
| cgmpvalidation.com | 1997 | Kansas, United States | – | 24 | Offers validation, compliance, and consulting services for life sciences sectors. | |
| sublimestericeuticals.com | 2018 | Ames, United States | – | – | Develops continuous lyophilization processes for stabilizing injectable medicines and vaccines. | |
| rubizon.com | 2017 | Bengaluru, India | – | – | Provider of clinical process development, verification, analytical, quality management and regulatory services | |
| wickhamlabs.co.uk | 1962 | Gosport, United Kingdom | – | – | Provider of medical device & pharmaceutical product testing services | |
| nexageusa.com | 1999 | East Brunswick, United States | – | – | Regulatory compliance, quality assurance, and data analytics services are provided. | |
| marblemed.com | 1988 | Tallahassee, United States | – | – | Manufacturing validation services are provided for the biopharma sector. |
Detailed competitors of Daicel Pharma Services
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Daicel Pharma Services
The website of Daicel Pharma Services (daicelpharmaservices.com) receives about 2K visits a month.
- Monthly visits2K
▲ 218.7% vs previous month
Latest news on Daicel Pharma Services
Complete news archive for Daicel Pharma Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Daicel Pharma Services
10 companies that operate in the same segment as Daicel Pharma Services (Toxicology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | – | – | |
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | – | – | |
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 | |
Non-invasive drug testing technology is developed using fingerprints. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 25.71 M | – | – | |
Provides toxicology, chemistry, and consultancy services for agrochemical industries. | 2020 | Vapi, Gujarat, India | – | – | – | |
Instruments for rapid human DNA identification are developed. | 2006 | Pleasanton, California, United States | USD 92.06 M | USD 22.5 B | 78 | |
Oral therapies for snake bite treatment are developed. | 2015 | Corte Madera, California, United States | USD 16.48 M | – | – | |
Quantitative urine drug testing is provided for patient monitoring. | 2011 | San Diego, California, United States | – | – | 358 | |
Point-of-care platforms for heavy metal toxicity diagnostics are developed. | 1968 | Billerica, Massachusetts, United States | USD 34 M | – | – | |
Real-time trace gas analysis solutions are delivered using SIFT-MS technology. | 2002 | Christchurch, New Zealand | USD 11.9 M | USD 23.52 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Daicel Pharma Services
Daicel Pharma Services was founded in 2019.
Daicel Pharma Services is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Daicel Pharma Services has 368 employees.
The primary company behind Daicel Pharma Services, Daicel Chiral Technologies (India) Private Limited, reported revenue of ₹162 Cr for FY 2025, up 30% year on year.
Daicel Chiral Technologies delivers innovative analytical solutions to support drug development and regulatory compliance. Based in Hyderabad, India, they offer services such as general analytical testing, extractable and leachable studies, peptide bioassays, and quality management. They cater to domestic and international pharmaceutical companies, ensuring timely and cost-efficient support from development to commercialization, adhering to global standards like ISO certifications.
Daicel Pharma Services's top competitors include NexAge Technologies, AlphaLab Health and Rubizon.
Daicel Pharma Services offers Analytical Testing Services, Peptide Bioassays, and Extractable and Leachable Studies.
Daicel Pharma Services operates through Daicel Chiral Technologies (India) Private Limited.
The legal entities of Daicel Pharma Services currently have 5 directors, including Seiji Sakano, Lakshmi Narayana Chennuru, Tatsushi Murakami and others.